@prefix	rdfs:	<http://www.w3.org/2000/01/rdf-schema#>	.
@prefix	local:	<http://local/local.owl#>	.
@prefix	ncit:	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#>	.
@prefix	rdf:	<http://www.w3.org/1999/02/22-rdf-syntax-ns#>	.
@prefix	owl:	<http://www.w3.org/2002/07/owl#>	.

#### Statements ####

local:s32.1	a	rdf:Statement	;
	rdfs:label	"further largerscale confirm the longterm outcome of patients"	.

local:s32	a	rdf:Statement	;
	rdfs:label	"further largerscale needed to confirm the longterm outcome of patients"	.

local:s30	a	rdf:Statement	;
	rdfs:label	"patients treated with this drug"	.

local:s29	a	rdf:Statement	;
	rdfs:label	"our results indicate that selumetinib is an safe treatment for pediatric patients with symptomatic inoperable plexiform neurofibromas"	.

local:s28	a	rdf:Statement	;
	rdfs:label	"our results indicate that selumetinib is an effective treatment for pediatric patients with symptomatic inoperable plexiform neurofibromas"	.

local:s27	a	rdf:Statement	;
	rdfs:label	"diarrhea which had a pooled rate of 638 percent"	.

local:s25	a	rdf:Statement	;
	rdfs:label	"creatine kinase levels which had a pooled rate of 633 percent"	.

local:s21.1	a	rdf:Statement	;
	rdfs:label	"moderate quality of the evidence"	.

local:s21	a	rdf:Statement	;
	rdfs:label	"five studies had a very low to moderate quality of the evidence"	.

local:s20	a	rdf:Statement	;
	rdfs:label	"five studies involving 126 patients"	.

local:s19	a	rdf:Statement	;
	rdfs:label	"five studies involving 126 patients"	.

local:s18	a	rdf:Statement	;
	rdfs:label	"five studies included in our analysis"	.

local:s17.1	a	rdf:Statement	;
	rdfs:label	"using the grading of assessment"	.

local:s17	a	rdf:Statement	;
	rdfs:label	"the quality of the evidence assessed using the grading of assessment"	.

local:s16.1	a	rdf:Statement	;
	rdfs:label	"using the grading of recommendations"	.

local:s16	a	rdf:Statement	;
	rdfs:label	"the quality of the evidence assessed using the grading of recommendations"	.

local:s15.1	a	rdf:Statement	;
	rdfs:label	"using the grading of development"	.

local:s15	a	rdf:Statement	;
	rdfs:label	"the quality of the evidence assessed using the grading of development"	.

local:s14.1	a	rdf:Statement	;
	rdfs:label	"using the grading of evaluation system"	.

local:s14	a	rdf:Statement	;
	rdfs:label	"the quality of the evidence assessed using the grading of evaluation system"	.

local:s13	a	rdf:Statement	;
	rdfs:label	"the pooled proportion of adverse events also"	.

local:s12.2	a	rdf:Statement	;
	rdfs:label	"the dersimonianlaird method based on randomeffects modeling"	.

local:s12.1	a	rdf:Statement	;
	rdfs:label	"the pooled objective response rates using the dersimonianlaird method based on randomeffects modeling"	.

local:s12	a	rdf:Statement	;
	rdfs:label	"the pooled objective response rates calculated using the dersimonianlaird method based on randomeffects modeling"	.

local:s11.2	a	rdf:Statement	;
	rdfs:label	"the dersimonianlaird method based on randomeffects modeling"	.

local:s11.1	a	rdf:Statement	;
	rdfs:label	"using the dersimonianlaird method based on randomeffects modeling"	.

local:s11	a	rdf:Statement	;
	rdfs:label	"disease control rates calculated using the dersimonianlaird method based on randomeffects modeling"	.

local:s10	a	rdf:Statement	;
	rdfs:label	"original articles identified in pubmed up to january 28 2021"	.

local:s9	a	rdf:Statement	;
	rdfs:label	"original articles identified in embase up to january 28 2021"	.

local:s8	a	rdf:Statement	;
	rdfs:label	"original articles reporting the efficacy and safety of selumetinib in patients with neurofibromatosis type 1"	.

local:s7.1	a	rdf:Statement	;
	rdfs:label	"its efficacy and safety systematically evaluate the efficacy and safety of selumetinib in children with neurofibromatosis type 1"	.

local:s7	a	rdf:Statement	;
	rdfs:label	"its efficacy and safety conducted to systematically evaluate the efficacy and safety of selumetinib in children with neurofibromatosis type 1"	.

local:s6.2	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib is expected to transform the management of children with neurofibromatosis type 1 particularly those with symptomatic plexiform neurofibromas no systematic review summarized inoperable plexiform neurofibromas efficacy"	.

local:s6.1	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib transform the management of children with neurofibromatosis type 1 particularly those with symptomatic plexiform neurofibromas no systematic review"	.

local:s6	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib expected to transform the management of children with neurofibromatosis type 1 particularly those with symptomatic plexiform neurofibromas no systematic review"	.

local:s5	a	rdf:Statement	;
	rdfs:label	"safety based on the latest studies"	.

local:s4.2	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib is expected to transform the management of children with neurofibromatosis type 1 particularly those with symptomatic plexiform neurofibromas no systematic review summarized symptomatic plexiform neurofibromas efficacy"	.

local:s4.1	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib transform the management of children with neurofibromatosis type 1 particularly those with symptomatic plexiform neurofibromas no systematic review"	.

local:s4	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib expected to transform the management of children with neurofibromatosis type 1 particularly those with symptomatic plexiform neurofibromas no systematic review"	.

local:s3.3	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib is expected to transform the management of children with neurofibromatosis type 1 particularly those with inoperable plexiform neurofibromas no systematic review summarized symptomatic plexiform neurofibromas efficacy"	.

local:s3.2	a	rdf:Statement	;
	rdfs:label	"neurofibromatosis type 1 particularly those with inoperable plexiform neurofibromas no systematic review"	.

local:s3.1	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib transform the management of children with neurofibromatosis type 1 particularly those with inoperable plexiform"	.

local:s3	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib expected to transform the management of children with neurofibromatosis type 1 particularly those with inoperable plexiform"	.

local:s2.3	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib is expected to transform the management of children with neurofibromatosis type 1 particularly those with inoperable plexiform neurofibromas no systematic review summarized safety"	.

local:s2.2	a	rdf:Statement	;
	rdfs:label	"neurofibromatosis type 1 particularly those with inoperable plexiform neurofibromas no systematic review"	.

local:s2.1	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib transform the management of children with neurofibromatosis type 1 particularly those with inoperable plexiform neurofibromas no systematic review"	.

local:s2	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib expected to transform the management of children with neurofibromatosis type 1 particularly those with inoperable plexiform"	.

local:s1.3	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib is expected to transform the management of children with neurofibromatosis type 1 particularly those with inoperable plexiform neurofibromas no systematic review summarized inoperable plexiform neurofibromas efficacy"	.

local:s1.2	a	rdf:Statement	;
	rdfs:label	"neurofibromatosis type 1 particularly those with inoperable plexiform neurofibromas no systematic review"	.

local:s1.1	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib transform the management of children with neurofibromatosis type 1 particularly those with inoperable plexiform"	.

local:s1	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib expected to transform the management of children with neurofibromatosis type 1 particularly those with inoperable plexiform"	.

local:s0.2	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib is expected to transform the management of children with neurofibromatosis type 1 particularly those with symptomatic plexiform neurofibromas no systematic review summarized safety"	.

local:s0.1	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib transform the management of children with neurofibromatosis type 1 particularly those with symptomatic plexiform neurofibromas no systematic review"	.

local:s0	a	rdf:Statement	;
	rdfs:label	"the recent approval of selumetinib expected to transform the management of children with neurofibromatosis type 1 particularly those with symptomatic plexiform neurofibromas no systematic review"	.


#### Classes ####

local:largerscale	a	rdf:Class	;
	rdfs:label	"largerscale"	.

local:confirm	a	rdf:Class	;
	rdfs:label	"confirm"	.

local:longterm_outcome_of_patient	a	rdf:Class	;
	rdfs:label	"longterm outcome of patient"	.

local:patient	a	rdf:Class	;
	rdfs:label	"patient"	.

local:longterm_outcome	a	rdf:Class	;
	rdfs:label	"longterm outcome"	.

local:longterm	a	rdf:Class	;
	rdfs:label	"longterm"	.

local:outcome	a	rdf:Class	;
	rdfs:label	"outcome"	.

local:need	a	rdf:Class	;
	rdfs:label	"need"	.

local:confirm_the_longterm_outcome_of_patient	a	rdf:Class	;
	rdfs:label	"confirm the longterm outcome of patient"	.

local:treat	a	rdf:Class	;
	rdfs:label	"treat"	.

local:drug	a	rdf:Class	;
	rdfs:label	"drug"	.

local:result	a	rdf:Class	;
	rdfs:label	"result"	.

local:indicate	a	rdf:Class	;
	rdfs:label	"indicate"	.

local:selumetinib_be_an_safe_treatment_for_pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	a	rdf:Class	;
	rdfs:label	"selumetinib be an safe treatment for pediatric patient with symptomatic inoperable plexiform neurofibroma"	.

local:pediatric_patient	a	rdf:Class	;
	rdfs:label	"pediatric patient"	.

local:safe_treatment	a	rdf:Class	;
	rdfs:label	"safe treatment"	.

local:symptomatic_inoperable_plexiform_neurofibroma	a	rdf:Class	;
	rdfs:label	"symptomatic inoperable plexiform neurofibroma"	.

local:selumetinib	a	rdf:Class	;
	rdfs:label	"selumetinib"	.

local:symptomatic_inoperable_plexiform	a	rdf:Class	;
	rdfs:label	"symptomatic inoperable plexiform"	.

local:symptomatic_inoperable	a	rdf:Class	;
	rdfs:label	"symptomatic inoperable"	.

local:inoperable_plexiform_neurofibroma	a	rdf:Class	;
	rdfs:label	"inoperable plexiform neurofibroma"	.

local:neurofibroma	a	rdf:Class	;
	rdfs:label	"neurofibroma"	.

local:plexiform_neurofibroma	a	rdf:Class	;
	rdfs:label	"plexiform neurofibroma"	.

local:symptomatic	a	rdf:Class	;
	rdfs:label	"symptomatic"	.

local:inoperable_plexiform	a	rdf:Class	;
	rdfs:label	"inoperable plexiform"	.

local:plexiform	a	rdf:Class	;
	rdfs:label	"plexiform"	.

local:safe	a	rdf:Class	;
	rdfs:label	"safe"	.

local:inoperable	a	rdf:Class	;
	rdfs:label	"inoperable"	.

local:treatment	a	rdf:Class	;
	rdfs:label	"treatment"	.

local:pediatric	a	rdf:Class	;
	rdfs:label	"pediatric"	.

local:safe_treatment_for_pediatric_patient	a	rdf:Class	;
	rdfs:label	"safe treatment for pediatric patient"	.

local:pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	a	rdf:Class	;
	rdfs:label	"pediatric patient with symptomatic inoperable plexiform neurofibroma"	.

local:selumetinib_be_an_effective_treatment_for_pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	a	rdf:Class	;
	rdfs:label	"selumetinib be an effective treatment for pediatric patient with symptomatic inoperable plexiform neurofibroma"	.

local:effective_treatment	a	rdf:Class	;
	rdfs:label	"effective treatment"	.

local:effective	a	rdf:Class	;
	rdfs:label	"effective"	.

local:effective_treatment_for_pediatric_patient	a	rdf:Class	;
	rdfs:label	"effective treatment for pediatric patient"	.

local:diarrhea	a	rdf:Class	;
	rdfs:label	"diarrhea"	.

local:have	a	rdf:Class	;
	rdfs:label	"have"	.

local:pool_rate_of_638_percent	a	rdf:Class	;
	rdfs:label	"pool rate of 638 percent"	.

local:percent	a	rdf:Class	;
	rdfs:label	"percent"	.

local:pool_rate	a	rdf:Class	;
	rdfs:label	"pool rate"	.

local:pool	a	rdf:Class	;
	rdfs:label	"pool"	.

local:rate	a	rdf:Class	;
	rdfs:label	"rate"	.

local:638_percent	a	rdf:Class	;
	rdfs:label	"638 percent"	.

local:creatine_kinase_level	a	rdf:Class	;
	rdfs:label	"creatine kinase level"	.

local:creatine_kinase	a	rdf:Class	;
	rdfs:label	"creatine kinase"	.

local:creatine	a	rdf:Class	;
	rdfs:label	"creatine"	.

local:kinase_level	a	rdf:Class	;
	rdfs:label	"kinase level"	.

local:kinase	a	rdf:Class	;
	rdfs:label	"kinase"	.

local:level	a	rdf:Class	;
	rdfs:label	"level"	.

local:pool_rate_of_633_percent	a	rdf:Class	;
	rdfs:label	"pool rate of 633 percent"	.

local:633_percent	a	rdf:Class	;
	rdfs:label	"633 percent"	.

local:quality_of_the_evidence	a	rdf:Class	;
	rdfs:label	"quality of the evidence"	.

local:evidence	a	rdf:Class	;
	rdfs:label	"evidence"	.

local:quality	a	rdf:Class	;
	rdfs:label	"quality"	.

local:quality_of_evidence	a	rdf:Class	;
	rdfs:label	"quality of evidence"	.

local:moderate	a	rdf:Class	;
	rdfs:label	"moderate"	.

local:five_study	a	rdf:Class	;
	rdfs:label	"five study"	.

local:study	a	rdf:Class	;
	rdfs:label	"study"	.

local:low_to_moderate_quality_of_the_evidence	a	rdf:Class	;
	rdfs:label	"low to moderate quality of the evidence"	.

local:moderate_quality	a	rdf:Class	;
	rdfs:label	"moderate quality"	.

local:low_to_moderate_quality	a	rdf:Class	;
	rdfs:label	"low to moderate quality"	.

local:low	a	rdf:Class	;
	rdfs:label	"low"	.

local:moderate_quality_of_evidence	a	rdf:Class	;
	rdfs:label	"moderate quality of evidence"	.

local:126_patient	a	rdf:Class	;
	rdfs:label	"126 patient"	.

local:involve	a	rdf:Class	;
	rdfs:label	"involve"	.

local:include	a	rdf:Class	;
	rdfs:label	"include"	.

local:five_study_analysis	a	rdf:Class	;
	rdfs:label	"five study analysis"	.

local:study_analysis	a	rdf:Class	;
	rdfs:label	"study analysis"	.

local:analysis	a	rdf:Class	;
	rdfs:label	"analysis"	.

local:grade_of_assessment	a	rdf:Class	;
	rdfs:label	"grade of assessment"	.

local:grade	a	rdf:Class	;
	rdfs:label	"grade"	.

local:assessment	a	rdf:Class	;
	rdfs:label	"assessment"	.

local:use	a	rdf:Class	;
	rdfs:label	"use"	.

local:assess	a	rdf:Class	;
	rdfs:label	"assess"	.

local:use_the_grade_of_assessment	a	rdf:Class	;
	rdfs:label	"use the grade of assessment"	.

local:grade_of_recommendation	a	rdf:Class	;
	rdfs:label	"grade of recommendation"	.

local:recommendation	a	rdf:Class	;
	rdfs:label	"recommendation"	.

local:use_the_grade_of_recommendation	a	rdf:Class	;
	rdfs:label	"use the grade of recommendation"	.

local:grade_of_development	a	rdf:Class	;
	rdfs:label	"grade of development"	.

local:development	a	rdf:Class	;
	rdfs:label	"development"	.

local:use_the_grade_of_development	a	rdf:Class	;
	rdfs:label	"use the grade of development"	.

local:grade_of_evaluation_system	a	rdf:Class	;
	rdfs:label	"grade of evaluation system"	.

local:evaluation_system	a	rdf:Class	;
	rdfs:label	"evaluation system"	.

local:evaluation	a	rdf:Class	;
	rdfs:label	"evaluation"	.

local:system	a	rdf:Class	;
	rdfs:label	"system"	.

local:use_the_grade_of_evaluation_system	a	rdf:Class	;
	rdfs:label	"use the grade of evaluation system"	.

local:pool_proportion_of_adverse_event	a	rdf:Class	;
	rdfs:label	"pool proportion of adverse event"	.

local:adverse_event	a	rdf:Class	;
	rdfs:label	"adverse event"	.

local:pool_proportion	a	rdf:Class	;
	rdfs:label	"pool proportion"	.

local:proportion	a	rdf:Class	;
	rdfs:label	"proportion"	.

local:adverse	a	rdf:Class	;
	rdfs:label	"adverse"	.

local:event	a	rdf:Class	;
	rdfs:label	"event"	.

local:calculate	a	rdf:Class	;
	rdfs:label	"calculate"	.

local:also	a	rdf:Class	;
	rdfs:label	"also"	.

local:dersimonianlaird_method	a	rdf:Class	;
	rdfs:label	"dersimonianlaird method"	.

local:method	a	rdf:Class	;
	rdfs:label	"method"	.

local:dersimonianlaird	a	rdf:Class	;
	rdfs:label	"dersimonianlaird"	.

local:base	a	rdf:Class	;
	rdfs:label	"base"	.

local:randomeffects_model	a	rdf:Class	;
	rdfs:label	"randomeffects model"	.

local:model	a	rdf:Class	;
	rdfs:label	"model"	.

local:randomeffects	a	rdf:Class	;
	rdfs:label	"randomeffects"	.

local:dersimonianlaird_method_base_on_randomeffects_model	a	rdf:Class	;
	rdfs:label	"dersimonianlaird method base on randomeffects model"	.

local:dersimonianlaird_method_base	a	rdf:Class	;
	rdfs:label	"dersimonianlaird method base"	.

local:method_base	a	rdf:Class	;
	rdfs:label	"method base"	.

local:pool_objective_response_rat	a	rdf:Class	;
	rdfs:label	"pool objective response rat"	.

local:objective_response_rat	a	rdf:Class	;
	rdfs:label	"objective response rat"	.

local:response_rat	a	rdf:Class	;
	rdfs:label	"response rat"	.

local:rat	a	rdf:Class	;
	rdfs:label	"rat"	.

local:objective_response	a	rdf:Class	;
	rdfs:label	"objective response"	.

local:response	a	rdf:Class	;
	rdfs:label	"response"	.

local:objective	a	rdf:Class	;
	rdfs:label	"objective"	.

local:use_the_dersimonianlaird_method_base_on_randomeffects_model	a	rdf:Class	;
	rdfs:label	"use the dersimonianlaird method base on randomeffects model"	.

local:use_on_randomeffects_model	a	rdf:Class	;
	rdfs:label	"use on randomeffects model"	.

local:disease_control_rat	a	rdf:Class	;
	rdfs:label	"disease control rat"	.

local:disease_control	a	rdf:Class	;
	rdfs:label	"disease control"	.

local:control	a	rdf:Class	;
	rdfs:label	"control"	.

local:control_rat	a	rdf:Class	;
	rdfs:label	"control rat"	.

local:disease	a	rdf:Class	;
	rdfs:label	"disease"	.

local:original_article	a	rdf:Class	;
	rdfs:label	"original article"	.

local:article	a	rdf:Class	;
	rdfs:label	"article"	.

local:original	a	rdf:Class	;
	rdfs:label	"original"	.

local:identify	a	rdf:Class	;
	rdfs:label	"identify"	.

local:pubmed_up_to_january_28_2021	a	rdf:Class	;
	rdfs:label	"pubmed up to january 28 2021"	.

local:28_january	a	rdf:Class	;
	rdfs:label	"28 january"	.

local:january	a	rdf:Class	;
	rdfs:label	"january"	.

local:pubmed_to_28_january	a	rdf:Class	;
	rdfs:label	"pubmed to 28 january"	.

local:pubmed	a	rdf:Class	;
	rdfs:label	"pubmed"	.

local:embase_up_to_january_28_2021	a	rdf:Class	;
	rdfs:label	"embase up to january 28 2021"	.

local:up_embase	a	rdf:Class	;
	rdfs:label	"up embase"	.

local:embase	a	rdf:Class	;
	rdfs:label	"embase"	.

local:up_to_28_january	a	rdf:Class	;
	rdfs:label	"up to 28 january"	.

local:up	a	rdf:Class	;
	rdfs:label	"up"	.

local:report	a	rdf:Class	;
	rdfs:label	"report"	.

local:efficacy_and_safety_of_selumetinib_in_patient	a	rdf:Class	;
	rdfs:label	"efficacy and safety of selumetinib in patient"	.

local:safety	a	rdf:Class	;
	rdfs:label	"safety"	.

local:efficacy	a	rdf:Class	;
	rdfs:label	"efficacy"	.

local:efficacy_of_selumetinib	a	rdf:Class	;
	rdfs:label	"efficacy of selumetinib"	.

local:efficacy_of_selumetinib_in_patient	a	rdf:Class	;
	rdfs:label	"efficacy of selumetinib in patient"	.

local:neurofibromatosis_type_1	a	rdf:Class	;
	rdfs:label	"neurofibromatosis type 1"	.

local:neurofibromatosis_type	a	rdf:Class	;
	rdfs:label	"neurofibromatosis type"	.

local:type	a	rdf:Class	;
	rdfs:label	"type"	.

local:neurofibromatosis	a	rdf:Class	;
	rdfs:label	"neurofibromatosis"	.

local:1_type	a	rdf:Class	;
	rdfs:label	"1 type"	.

local:neurofibromatosis_1_type	a	rdf:Class	;
	rdfs:label	"neurofibromatosis 1 type"	.

local:efficacy_and_safety	a	rdf:Class	;
	rdfs:label	"efficacy and safety"	.

local:evaluate	a	rdf:Class	;
	rdfs:label	"evaluate"	.

local:efficacy_and_safety_of_selumetinib_in_child	a	rdf:Class	;
	rdfs:label	"efficacy and safety of selumetinib in child"	.

local:child	a	rdf:Class	;
	rdfs:label	"child"	.

local:efficacy_of_selumetinib_in_child	a	rdf:Class	;
	rdfs:label	"efficacy of selumetinib in child"	.

local:systematically	a	rdf:Class	;
	rdfs:label	"systematically"	.

local:conduct	a	rdf:Class	;
	rdfs:label	"conduct"	.

local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	a	rdf:Class	;
	rdfs:label	"recent approval of selumetinib be expect to transform the management of child with neurofibromatosis type 1 particularly those with symptomatic plexiform neurofibroma no systematic review"	.

local:symptomatic_plexiform_neurofibroma	a	rdf:Class	;
	rdfs:label	"symptomatic plexiform neurofibroma"	.

local:recent_approval	a	rdf:Class	;
	rdfs:label	"recent approval"	.

local:management	a	rdf:Class	;
	rdfs:label	"management"	.

local:systematic_review	a	rdf:Class	;
	rdfs:label	"systematic review"	.

local:symptomatic_plexiform	a	rdf:Class	;
	rdfs:label	"symptomatic plexiform"	.

local:recent	a	rdf:Class	;
	rdfs:label	"recent"	.

local:review	a	rdf:Class	;
	rdfs:label	"review"	.

local:systematic	a	rdf:Class	;
	rdfs:label	"systematic"	.

local:approval	a	rdf:Class	;
	rdfs:label	"approval"	.

local:review_those	a	rdf:Class	;
	rdfs:label	"review those"	.

local:those	a	rdf:Class	;
	rdfs:label	"those"	.

local:no_systematic_review	a	rdf:Class	;
	rdfs:label	"no systematic review"	.

local:particularly_review_those	a	rdf:Class	;
	rdfs:label	"particularly review those"	.

local:be_expect	a	rdf:Class	;
	rdfs:label	"be expect"	.

local:expect	a	rdf:Class	;
	rdfs:label	"expect"	.

local:recent_approval_of_selumetinib	a	rdf:Class	;
	rdfs:label	"recent approval of selumetinib"	.

local:management_of_child	a	rdf:Class	;
	rdfs:label	"management of child"	.

local:transform_with_neurofibromatosis_1_type	a	rdf:Class	;
	rdfs:label	"transform with neurofibromatosis 1 type"	.

local:transform	a	rdf:Class	;
	rdfs:label	"transform"	.

local:particularly_review_those_with_symptomatic_plexiform_neurofibroma	a	rdf:Class	;
	rdfs:label	"particularly review those with symptomatic plexiform neurofibroma"	.

local:summarize	a	rdf:Class	;
	rdfs:label	"summarize"	.

local:inoperable_plexiform_neurofibroma_efficacy	a	rdf:Class	;
	rdfs:label	"inoperable plexiform neurofibroma efficacy"	.

local:neurofibroma_efficacy	a	rdf:Class	;
	rdfs:label	"neurofibroma efficacy"	.

local:plexiform_neurofibroma_efficacy	a	rdf:Class	;
	rdfs:label	"plexiform neurofibroma efficacy"	.

local:management_of_child_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	a	rdf:Class	;
	rdfs:label	"management of child neurofibromatosis type 1 particularly those with symptomatic plexiform neurofibroma no systematic review"	.

local:child_neurofibromatosis	a	rdf:Class	;
	rdfs:label	"child neurofibromatosis"	.

local:child_neurofibromatosis_1_type	a	rdf:Class	;
	rdfs:label	"child neurofibromatosis 1 type"	.

local:management_of_child_neurofibromatosis_1_type	a	rdf:Class	;
	rdfs:label	"management of child neurofibromatosis 1 type"	.

local:latest_study	a	rdf:Class	;
	rdfs:label	"latest study"	.

local:latest	a	rdf:Class	;
	rdfs:label	"latest"	.

local:symptomatic_plexiform_neurofibroma_efficacy	a	rdf:Class	;
	rdfs:label	"symptomatic plexiform neurofibroma efficacy"	.

local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	a	rdf:Class	;
	rdfs:label	"recent approval of selumetinib be expect to transform the management of child with neurofibromatosis type 1 particularly those with inoperable plexiform neurofibroma no systematic review"	.

local:particularly_review_those_with_inoperable_plexiform_neurofibroma	a	rdf:Class	;
	rdfs:label	"particularly review those with inoperable plexiform neurofibroma"	.

local:neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform	a	rdf:Class	;
	rdfs:label	"neurofibromatosis type 1 particularly those with inoperable plexiform"	.

local:particularly_those	a	rdf:Class	;
	rdfs:label	"particularly those"	.

local:particularly_those_with_inoperable_plexiform	a	rdf:Class	;
	rdfs:label	"particularly those with inoperable plexiform"	.

local:neurofibromas	a	rdf:Class	;
	rdfs:label	"neurofibromas"	.

local:management_of_child_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform	a	rdf:Class	;
	rdfs:label	"management of child neurofibromatosis type 1 particularly those with inoperable plexiform"	.

local:management_of_child_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	a	rdf:Class	;
	rdfs:label	"management of child neurofibromatosis type 1 particularly those with inoperable plexiform neurofibroma no systematic review"	.

#### Mapped Relations ####

ncit:C54722	rdfs:label	"Low"	.
ncit:C76125	rdfs:label	"Experimental Result"	.
ncit:C84377	rdfs:label	"Development"	.
ncit:C3797	rdfs:label	"Plexiform Neurofibroma"	.
local:pediatric	owl:sameAs	ncit:C39299	.
ncit:C113245	rdfs:label	"Creatine Kinase"	.
ncit:C54125	rdfs:label	"Calculation"	.
local:kinase	owl:sameAs	ncit:C28597	.
local:neurofibroma	owl:sameAs	ncit:C3272	.
ncit:C47902	rdfs:label	"Article"	.
local:report	owl:sameAs	ncit:C25375	.
local:response	owl:sameAs	ncit:C25755	.
ncit:C42881	rdfs:label	"PubMed"	.
ncit:C2987	rdfs:label	"Diarrhea"	.
ncit:C20200	rdfs:label	"Outcome"	.
local:neurofibromatosis	owl:sameAs	ncit:C6727	.
ncit:C74521	rdfs:label	"Include"	.
ncit:C25284	rdfs:label	"Type"	.
ncit:C16423	rdfs:label	"Child"	.
ncit:C61299	rdfs:label	"Control"	.
ncit:C106180	rdfs:label	"January"	.
ncit:C64247	rdfs:label	"Inoperable"	.
local:method	owl:sameAs	ncit:C71460	.
local:safe	owl:sameAs	ncit:C142675	.
ncit:C16326	rdfs:label	"Behavior"	.
local:pool	owl:sameAs	ncit:C68779	.
ncit:C63536	rdfs:label	"Study"	.
ncit:C71460	rdfs:label	"Method"	.
local:selumetinib	owl:sameAs	ncit:C66939	.
ncit:C6727	rdfs:label	"Neurofibromatosis"	.
local:approval	owl:sameAs	ncit:C25425	.
local:effective	owl:sameAs	ncit:C49287	.
local:percent	owl:sameAs	ncit:C48570	.
ncit:C25604	rdfs:label	"Original"	.
local:patient	owl:sameAs	ncit:C16960	.
ncit:C43583	rdfs:label	"Evidence"	.
ncit:C61372	rdfs:label	"Management"	.
local:treatment	owl:sameAs	ncit:C49656	.
local:event	owl:sameAs	ncit:C25499	.
local:january	owl:sameAs	ncit:C106180	.
ncit:C142675	rdfs:label	"SAFE-Biopharma Standard"	.
local:disease	owl:sameAs	ncit:C2991	.
local:confirm	owl:sameAs	ncit:C181549	.
local:rat	owl:sameAs	ncit:C160998	.
local:recent	owl:sameAs	ncit:C25280	.
ncit:C28597	rdfs:label	"Kinase"	.
local:review	owl:sameAs	ncit:C42729	.
ncit:C42729	rdfs:label	"Review"	.
local:original	owl:sameAs	ncit:C25604	.
local:response_rat	owl:sameAs	ncit:C94502	.
ncit:C25755	rdfs:label	"Response"	.
local:treat	owl:sameAs	ncit:C70742	.
ncit:C48570	rdfs:label	"Percent Unit"	.
ncit:C49159	rdfs:label	"Proportion"	.
ncit:C39299	rdfs:label	"Pediatric"	.
ncit:C25554	rdfs:label	"Level"	.
local:need	owl:sameAs	ncit:C41204	.
ncit:C68779	rdfs:label	"Pool"	.
local:creatine	owl:sameAs	ncit:C37937	.
local:rate	owl:sameAs	ncit:C25636	.
ncit:C61376	rdfs:label	"Moderate"	.
ncit:C25217	rdfs:label	"Assessment"	.
ncit:C43383	rdfs:label	"Model"	.
ncit:C41204	rdfs:label	"Need"	.
ncit:C60828	rdfs:label	"Safety"	.
local:diarrhea	owl:sameAs	ncit:C2987	.
ncit:C48055	rdfs:label	"Base"	.
local:objective	owl:sameAs	ncit:C88181	.
ncit:C49656	rdfs:label	"Treatment Study"	.
local:base	owl:sameAs	ncit:C48055	.
ncit:C66939	rdfs:label	"Selumetinib"	.
local:type	owl:sameAs	ncit:C25284	.
local:quality	owl:sameAs	ncit:C25283	.
local:evidence	owl:sameAs	ncit:C43583	.
ncit:C101282	rdfs:label	"Have"	.
local:low	owl:sameAs	ncit:C54722	.
local:creatine_kinase	owl:sameAs	ncit:C113245	.
local:system	owl:sameAs	ncit:C25700	.
ncit:C49287	rdfs:label	"Effective"	.
ncit:C25499	rdfs:label	"Event"	.
ncit:C2991	rdfs:label	"Disease or Disorder"	.
local:neurofibromatosis_type_1	owl:sameAs	ncit:C3273	.
local:plexiform_neurofibroma	owl:sameAs	ncit:C3797	.
local:child	owl:sameAs	ncit:C16423	.
ncit:C25283	rdfs:label	"Quality"	.
ncit:C25280	rdfs:label	"Recent"	.
ncit:C41331	rdfs:label	"Adverse Event"	.
local:outcome	owl:sameAs	ncit:C20200	.
ncit:C160998	rdfs:label	"Rat"	.
local:evaluate	owl:sameAs	ncit:C25214	.
local:management	owl:sameAs	ncit:C61372	.
ncit:C25269	rdfs:label	"Symptomatic"	.
local:inoperable	owl:sameAs	ncit:C64247	.
local:include	owl:sameAs	ncit:C74521	.
ncit:C25700	rdfs:label	"System"	.
ncit:C25214	rdfs:label	"Evaluation"	.
local:safety	owl:sameAs	ncit:C60828	.
ncit:C3273	rdfs:label	"Neurofibromatosis Type 1"	.
local:pubmed	owl:sameAs	ncit:C42881	.
ncit:C25636	rdfs:label	"Rate"	.
ncit:C48309	rdfs:label	"Grade"	.
ncit:C25197	rdfs:label	"Recommendation"	.
ncit:C25425	rdfs:label	"Approval"	.
local:study	owl:sameAs	ncit:C63536	.
ncit:C16960	rdfs:label	"Patient"	.
local:result	owl:sameAs	ncit:C76125	.
ncit:C37937	rdfs:label	"Creatine"	.
ncit:C181549	rdfs:label	"Confirmatory Test"	.
local:have	owl:sameAs	ncit:C101282	.
local:calculate	owl:sameAs	ncit:C54125	.
ncit:C25391	rdfs:label	"Analysis"	.
local:model	owl:sameAs	ncit:C43383	.
local:control	owl:sameAs	ncit:C61299	.
local:level	owl:sameAs	ncit:C25554	.
local:moderate	owl:sameAs	ncit:C61376	.
local:neurofibromas	owl:sameAs	ncit:C3272	.
ncit:C88181	rdfs:label	"Objective"	.
local:article	owl:sameAs	ncit:C47902	.
local:proportion	owl:sameAs	ncit:C49159	.
ncit:C25340	rdfs:label	"Use"	.
local:assessment	owl:sameAs	ncit:C25217	.
local:adverse_event	owl:sameAs	ncit:C41331	.
local:analysis	owl:sameAs	ncit:C25391	.
local:evaluation	owl:sameAs	ncit:C25214	.
ncit:C94502	rdfs:label	"Response Rate"	.
local:use	owl:sameAs	ncit:C25340	.
ncit:C459	rdfs:label	"Medication"	.
local:conduct	owl:sameAs	ncit:C16326	.
ncit:C70742	rdfs:label	"Treat"	.
ncit:C3272	rdfs:label	"Neurofibroma"	.
local:grade	owl:sameAs	ncit:C48309	.
local:recommendation	owl:sameAs	ncit:C25197	.
local:symptomatic	owl:sameAs	ncit:C25269	.
local:development	owl:sameAs	ncit:C84377	.
ncit:C25375	rdfs:label	"Report"	.
local:drug	owl:sameAs	ncit:C459	.

#### Relations ####

local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:symptomatic_plexiform_neurofibroma	.
local:moderate_quality_of_evidence	rdfs:member	local:moderate_quality	.
local:s18	rdf:predicate	local:include	.
local:symptomatic_inoperable	rdfs:subClassOf	local:inoperable	.
local:s10	rdf:predicate	local:identify	.
local:objective_response_rat	rdfs:member	local:objective_response	.
local:evaluation_system	rdfs:subClassOf	local:system	.
local:s12.1	rdf:subject	local:dersimonianlaird_method_base_on_randomeffects_model	.
local:neurofibroma_efficacy	rdfs:subClassOf	local:efficacy	.
local:s10	rdf:subject	local:original_article	.
local:low_to_moderate_quality_of_the_evidence	rdfs:member	local:quality	.
local:s4	rdf:subject	local:recent_approval_of_selumetinib	.
local:s11.1	rdf:predicate	local:use	.
local:symptomatic_inoperable_plexiform_neurofibroma	rdfs:member	local:symptomatic_inoperable_plexiform	.
local:objective_response_rat	rdfs:subClassOf	local:response_rat	.
local:randomeffects_model	rdfs:subClassOf	local:model	.
local:creatine_kinase_level	rdfs:subClassOf	local:level	.
local:efficacy_of_selumetinib_in_patient	rdfs:member	local:patient	.
local:28_january	rdfs:subClassOf	local:january	.
local:s14.1	rdf:subject	local:grade_of_evaluation_system	.
local:s6.2	rdf:object	local:inoperable_plexiform_neurofibroma_efficacy	.
local:s28	rdf:subject	local:result	.
local:selumetinib_be_an_effective_treatment_for_pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	rdfs:member	local:pediatric_patient	.
local:use_the_grade_of_recommendation	rdfs:member	local:grade	.
local:s15	local:AM-ADV	local:use_the_grade_of_development	.
local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:systematic_review	.
local:s2	rdf:subject	local:recent_approval_of_selumetinib	.
local:s32	rdf:subject	local:largerscale	.
local:s15.1	rdf:predicate	local:use	.
local:up_to_28_january	rdfs:member	local:28_january	.
local:control_rat	rdfs:member	local:control	.
local:inoperable_plexiform_neurofibroma_efficacy	rdfs:member	local:inoperable_plexiform_neurofibroma	.
local:management_of_child_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform	rdfs:member	local:inoperable_plexiform	.
local:low_to_moderate_quality	rdfs:member	local:low	.
local:grade_of_assessment	rdfs:member	local:grade	.
local:s3.3	rdf:predicate	local:summarize	.
local:safe_treatment_for_pediatric_patient	rdfs:member	local:safe_treatment	.
local:s3.1	rdf:object	local:management_of_child_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform	.
local:use_the_grade_of_development	rdfs:member	local:grade	.
local:management_of_child_neurofibromatosis_1_type	rdfs:member	local:child_neurofibromatosis_1_type	.
local:management_of_child_neurofibromatosis_1_type	rdfs:member	local:management	.
local:management_of_child_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform	rdfs:member	local:management	.
local:objective_response_rat	rdfs:subClassOf	local:rat	.
local:s16	rdf:subject	local:quality_of_the_evidence	.
local:s2.3	rdf:object	local:safety	.
local:s2.3	rdf:subject	local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	.
local:management_of_child_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:management	.
local:s2	rdf:predicate	local:expect	.
local:s14	local:AM-ADV	local:use_the_grade_of_evaluation_system	.
local:s19	rdf:subject	local:126_patient	.
local:longterm_outcome	rdfs:member	local:longterm	.
local:moderate_quality_of_evidence	rdfs:member	local:evidence	.
local:selumetinib_be_an_safe_treatment_for_pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	rdfs:member	local:pediatric_patient	.
local:pool_objective_response_rat	rdfs:member	local:pool	.
local:s4.1	rdf:object	local:management_of_child_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	.
local:study_analysis	rdfs:member	local:study	.
local:pool_proportion_of_adverse_event	rdfs:member	local:pool_proportion	.
local:symptomatic_plexiform	rdfs:member	local:symptomatic	.
local:inoperable_plexiform_neurofibroma	rdfs:subClassOf	local:neurofibroma	.
local:s0	rdf:predicate	local:expect	.
local:grade_of_recommendation	rdfs:member	local:recommendation	.
local:pool_objective_response_rat	rdfs:subClassOf	local:objective_response_rat	.
local:s21	rdf:subject	local:five_study	.
local:s17	rdf:predicate	local:assess	.
local:s30	rdf:object	local:drug	.
local:s11.2	rdf:object	local:randomeffects_model	.
local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:inoperable_plexiform_neurofibroma	.
local:s10	rdf:object	local:pubmed_up_to_january_28_2021	.
local:particularly_review_those_with_symptomatic_plexiform_neurofibroma	rdfs:member	local:particularly_review_those	.
local:s21	rdf:object	local:low_to_moderate_quality_of_the_evidence	.
local:s4.1	rdf:subject	local:recent_approval_of_selumetinib	.
local:safe_treatment	rdfs:member	local:safe	.
local:126_patient	rdfs:subClassOf	local:patient	.
local:pool_rate_of_633_percent	rdfs:member	local:633_percent	.
local:control_rat	rdfs:subClassOf	local:rat	.
local:s28	rdf:object	local:selumetinib_be_an_effective_treatment_for_pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	.
local:s3.2	rdf:predicate	local:neurofibromas	.
local:pediatric_patient	rdfs:subClassOf	local:patient	.
local:inoperable_plexiform_neurofibroma	rdfs:subClassOf	local:plexiform_neurofibroma	.
local:be_expect	rdfs:subClassOf	local:expect	.
local:plexiform_neurofibroma_efficacy	rdfs:member	local:plexiform_neurofibroma	.
local:pool_objective_response_rat	rdfs:member	local:objective_response_rat	.
local:s30	rdf:subject	local:patient	.
local:inoperable_plexiform_neurofibroma_efficacy	rdfs:subClassOf	local:plexiform_neurofibroma_efficacy	.
local:selumetinib_be_an_safe_treatment_for_pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	rdfs:member	local:selumetinib	.
local:s7.1	rdf:predicate	local:evaluate	.
local:particularly_review_those_with_inoperable_plexiform_neurofibroma	rdfs:member	local:inoperable_plexiform_neurofibroma	.
local:inoperable_plexiform_neurofibroma_efficacy	rdfs:subClassOf	local:efficacy	.
local:s5	local:AM-TMP	local:latest_study	.
local:s25	rdf:predicate	local:have	.
local:recent_approval	rdfs:member	local:recent	.
local:efficacy_and_safety_of_selumetinib_in_child	rdfs:member	local:selumetinib	.
local:s17.1	rdf:subject	local:grade_of_assessment	.
local:s29	rdf:subject	local:result	.
local:neurofibroma_efficacy	rdfs:member	local:neurofibroma	.
local:no_systematic_review	rdfs:subClassOf	local:systematic_review	.
local:s32	rdf:predicate	local:need	.
local:1_type	rdfs:subClassOf	local:type	.
local:up_embase	rdfs:subClassOf	local:embase	.
local:low_to_moderate_quality	rdfs:member	local:moderate_quality	.
local:s11.1	rdf:subject	local:dersimonianlaird_method_base_on_randomeffects_model	.
local:s13	rdf:subject	local:pool_proportion_of_adverse_event	.
local:symptomatic_plexiform_neurofibroma	rdfs:subClassOf	local:plexiform_neurofibroma	.
local:disease_control	rdfs:member	local:disease	.
local:s2.1	rdf:object	local:management_of_child_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	.
local:recent_approval_of_selumetinib	rdfs:member	local:selumetinib	.
local:child_neurofibromatosis	rdfs:member	local:child	.
local:s21.1	rdf:subject	local:quality_of_the_evidence	.
local:s2.3	rdf:predicate	local:summarize	.
local:pool_proportion	rdfs:member	local:pool	.
local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:neurofibromatosis_type	.
local:management_of_child	rdfs:member	local:management	.
local:randomeffects_model	rdfs:member	local:randomeffects	.
local:selumetinib_be_an_effective_treatment_for_pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	rdfs:member	local:effective_treatment	.
local:s12	rdf:predicate	local:calculate	.
local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:recent_approval	.
local:use_the_grade_of_assessment	rdfs:member	local:assessment	.
local:particularly_those	rdfs:subClassOf	local:those	.
local:s17	local:AM-ADV	local:use_the_grade_of_assessment	.
local:s3	rdf:subject	local:recent_approval_of_selumetinib	.
local:transform_with_neurofibromatosis_1_type	rdfs:member	local:neurofibromatosis_1_type	.
local:s9	rdf:predicate	local:identify	.
local:dersimonianlaird_method_base	rdfs:subClassOf	local:base	.
local:s3.2	rdf:object	local:systematic_review	.
local:efficacy_of_selumetinib	rdfs:member	local:efficacy	.
local:efficacy_of_selumetinib	rdfs:member	local:selumetinib	.
local:pool_rate_of_633_percent	rdfs:member	local:pool_rate	.
local:neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform	rdfs:member	local:neurofibromatosis_type	.
local:pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	rdfs:member	local:pediatric_patient	.
local:s27	rdf:predicate	local:have	.
local:pool_rate_of_633_percent	rdfs:member	local:percent	.
local:s4.2	rdf:object	local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	.
local:s2.2	rdf:predicate	local:neurofibromas	.
local:s6	rdf:predicate	local:expect	.
local:s11	rdf:subject	local:disease_control_rat	.
local:s4	rdf:predicate	local:expect	.
local:longterm_outcome_of_patient	rdfs:member	local:patient	.
local:s11.2	rdf:predicate	local:base	.
local:adverse_event	rdfs:member	local:adverse	.
local:grade_of_assessment	rdfs:member	local:assessment	.
local:use_the_grade_of_evaluation_system	rdfs:member	local:evaluation_system	.
local:s1.3	rdf:object	local:inoperable_plexiform_neurofibroma_efficacy	.
local:s29	rdf:object	local:selumetinib_be_an_safe_treatment_for_pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	.
local:original_article	rdfs:subClassOf	local:article	.
local:s20	rdf:object	local:five_study	.
local:grade_of_evaluation_system	rdfs:member	local:evaluation_system	.
local:use_the_dersimonianlaird_method_base_on_randomeffects_model	rdfs:member	local:dersimonianlaird_method_base	.
local:s25	rdf:subject	local:creatine_kinase_level	.
local:s19	rdf:object	local:five_study	.
local:response_rat	rdfs:subClassOf	local:rat	.
local:effective_treatment_for_pediatric_patient	rdfs:member	local:pediatric_patient	.
local:s14	rdf:subject	local:quality_of_the_evidence	.
local:s1.3	rdf:predicate	local:summarize	.
local:systematic_review	rdfs:subClassOf	local:review	.
local:s12.1	rdf:object	local:pool_objective_response_rat	.
local:s7	rdf:subject	local:efficacy_and_safety	.
local:s8	local:AM-MNR	local:neurofibromatosis_type_1	.
local:s5	rdf:subject	local:safety	.
local:quality_of_evidence	rdfs:member	local:evidence	.
local:s17.1	rdf:predicate	local:use	.
local:pubmed_to_28_january	rdfs:member	local:28_january	.
local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:management	.
local:latest_study	rdfs:member	local:latest	.
local:s28	rdf:predicate	local:indicate	.
local:s7.1	rdf:object	local:efficacy_and_safety_of_selumetinib_in_child	.
local:child_neurofibromatosis_1_type	rdfs:subClassOf	local:neurofibromatosis_1_type	.
local:use_on_randomeffects_model	rdfs:member	local:use	.
local:kinase_level	rdfs:subClassOf	local:level	.
local:s9	local:AM-TMP	local:embase_up_to_january_28_2021	.
local:s1	rdf:predicate	local:expect	.
local:grade_of_recommendation	rdfs:member	local:grade	.
local:efficacy_and_safety_of_selumetinib_in_patient	rdfs:member	local:selumetinib	.
local:management_of_child_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:systematic_review	.
local:s12.2	rdf:object	local:randomeffects_model	.
local:systematic_review	rdfs:member	local:systematic	.
local:neurofibromatosis_type	rdfs:member	local:neurofibromatosis	.
local:symptomatic_inoperable	rdfs:member	local:symptomatic	.
local:s13	local:AM-DIS	local:also	.
local:s3	rdf:predicate	local:expect	.
local:pediatric_patient	rdfs:member	local:pediatric	.
local:symptomatic_inoperable_plexiform	rdfs:member	local:symptomatic_inoperable	.
local:s0.1	rdf:predicate	local:transform	.
local:study_analysis	rdfs:subClassOf	local:analysis	.
local:efficacy_and_safety_of_selumetinib_in_patient	rdfs:member	local:safety	.
local:s3.2	rdf:subject	local:neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform	.
local:s11	local:AM-ADV	local:use_the_dersimonianlaird_method_base_on_randomeffects_model	.
local:symptomatic_plexiform_neurofibroma_efficacy	rdfs:subClassOf	local:plexiform_neurofibroma_efficacy	.
local:efficacy_and_safety_of_selumetinib_in_child	rdfs:member	local:efficacy	.
local:s1.3	rdf:subject	local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	.
local:s21	rdf:predicate	local:have	.
local:s8	rdf:predicate	local:report	.
local:s17	rdf:subject	local:quality_of_the_evidence	.
local:quality_of_evidence	rdfs:member	local:quality	.
local:symptomatic_inoperable_plexiform	rdfs:subClassOf	local:plexiform	.
local:s20	rdf:subject	local:126_patient	.
local:management_of_child_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform	rdfs:member	local:child_neurofibromatosis	.
local:use_the_grade_of_development	rdfs:member	local:development	.
local:638_percent	rdfs:subClassOf	local:percent	.
local:s3.3	rdf:object	local:symptomatic_plexiform_neurofibroma_efficacy	.
local:s3.3	rdf:subject	local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	.
local:s1.1	rdf:object	local:management_of_child_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform	.
local:management_of_child_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:management	.
local:moderate_quality	rdfs:subClassOf	local:quality	.
local:quality_of_the_evidence	rdfs:member	local:evidence	.
local:s32.1	rdf:predicate	local:confirm	.
local:plexiform_neurofibroma	rdfs:subClassOf	local:neurofibroma	.
local:method_base	rdfs:subClassOf	local:base	.
local:selumetinib_be_an_effective_treatment_for_pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	rdfs:member	local:symptomatic_inoperable_plexiform_neurofibroma	.
local:symptomatic_plexiform_neurofibroma_efficacy	rdfs:subClassOf	local:efficacy	.
local:response_rat	rdfs:member	local:response	.
local:s32	local:AM-PNC	local:confirm_the_longterm_outcome_of_patient	.
local:kinase_level	rdfs:member	local:kinase	.
local:particularly_review_those	rdfs:subClassOf	local:review_those	.
local:s4.2	rdf:subject	local:symptomatic_plexiform_neurofibroma_efficacy	.
local:s0.1	rdf:object	local:management_of_child_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	.
local:s1.1	rdf:subject	local:recent_approval_of_selumetinib	.
local:s7	rdf:predicate	local:conduct	.
local:creatine_kinase	rdfs:subClassOf	local:kinase	.
local:s30	rdf:predicate	local:treat	.
local:s16	rdf:predicate	local:assess	.
local:efficacy_and_safety_of_selumetinib_in_child	rdfs:member	local:child	.
local:use_the_grade_of_recommendation	rdfs:member	local:recommendation	.
local:low_to_moderate_quality_of_the_evidence	rdfs:member	local:evidence	.
local:s2.1	rdf:predicate	local:transform	.
local:five_study	rdfs:subClassOf	local:study	.
local:evaluation_system	rdfs:member	local:evaluation	.
local:particularly_those_with_inoperable_plexiform	rdfs:member	local:inoperable_plexiform	.
local:s11	rdf:predicate	local:calculate	.
local:s27	rdf:subject	local:diarrhea	.
local:s6.2	rdf:predicate	local:summarize	.
local:effective_treatment	rdfs:subClassOf	local:treatment	.
local:confirm_the_longterm_outcome_of_patient	rdfs:member	local:patient	.
local:s12.2	rdf:predicate	local:base	.
local:efficacy_and_safety	rdfs:member	local:safety	.
local:efficacy_of_selumetinib_in_child	rdfs:member	local:child	.
local:particularly_review_those_with_inoperable_plexiform_neurofibroma	rdfs:member	local:particularly_review_those	.
local:s11.2	rdf:subject	local:dersimonianlaird_method	.
local:dersimonianlaird_method_base	rdfs:subClassOf	local:method_base	.
local:pool_proportion_of_adverse_event	rdfs:member	local:adverse_event	.
local:particularly_review_those_with_symptomatic_plexiform_neurofibroma	rdfs:member	local:symptomatic_plexiform_neurofibroma	.
local:quality_of_the_evidence	rdfs:member	local:quality	.
local:method_base	rdfs:member	local:method	.
local:disease_control_rat	rdfs:subClassOf	local:control_rat	.
local:effective_treatment_for_pediatric_patient	rdfs:member	local:effective_treatment	.
local:efficacy_of_selumetinib_in_child	rdfs:member	local:efficacy_of_selumetinib	.
local:s3.1	rdf:subject	local:recent_approval_of_selumetinib	.
local:s12	local:AM-ADV	local:use_the_dersimonianlaird_method_base_on_randomeffects_model	.
local:s3.1	rdf:predicate	local:transform	.
local:pool_rate_of_638_percent	rdfs:member	local:638_percent	.
local:s21.1	rdf:predicate	local:moderate	.
local:grade_of_development	rdfs:member	local:development	.
local:s25	rdf:object	local:pool_rate_of_633_percent	.
local:selumetinib_be_an_effective_treatment_for_pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	rdfs:member	local:selumetinib	.
local:safe_treatment_for_pediatric_patient	rdfs:member	local:pediatric_patient	.
local:creatine_kinase	rdfs:member	local:creatine	.
local:recent_approval_of_selumetinib	rdfs:member	local:recent_approval	.
local:s32.1	rdf:subject	local:largerscale	.
local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:systematic_review	.
local:s2.1	rdf:subject	local:recent_approval_of_selumetinib	.
local:safe_treatment	rdfs:subClassOf	local:treatment	.
local:s16.1	rdf:subject	local:grade_of_recommendation	.
local:use_the_grade_of_evaluation_system	rdfs:member	local:grade	.
local:efficacy_and_safety_of_selumetinib_in_patient	rdfs:member	local:patient	.
local:disease_control	rdfs:subClassOf	local:control	.
local:s1.1	rdf:predicate	local:transform	.
local:symptomatic_plexiform_neurofibroma	rdfs:member	local:symptomatic_plexiform	.
local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:recent_approval	.
local:use_on_randomeffects_model	rdfs:member	local:randomeffects_model	.
local:neurofibromatosis_1_type	rdfs:subClassOf	local:1_type	.
local:efficacy_and_safety	rdfs:member	local:efficacy	.
local:creatine_kinase_level	rdfs:member	local:creatine_kinase	.
local:management_of_child_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:systematic_review	.
local:symptomatic_inoperable_plexiform_neurofibroma	rdfs:subClassOf	local:inoperable_plexiform_neurofibroma	.
local:s7.1	rdf:subject	local:efficacy_and_safety	.
local:child_neurofibromatosis	rdfs:subClassOf	local:neurofibromatosis	.
local:s13	rdf:predicate	local:calculate	.
local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:selumetinib	.
local:s0	rdf:subject	local:recent_approval_of_selumetinib	.
local:s18	rdf:object	local:five_study_analysis	.
local:s6.1	rdf:predicate	local:transform	.
local:dersimonianlaird_method_base	rdfs:member	local:dersimonianlaird_method	.
local:pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	rdfs:member	local:symptomatic_inoperable_plexiform_neurofibroma	.
local:s29	rdf:predicate	local:indicate	.
local:symptomatic_plexiform_neurofibroma	rdfs:subClassOf	local:neurofibroma	.
local:s7.1	local:AM-MNR	local:systematically	.
local:s19	rdf:predicate	local:involve	.
local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:selumetinib	.
local:inoperable_plexiform	rdfs:subClassOf	local:plexiform	.
local:s12.2	rdf:subject	local:dersimonianlaird_method	.
local:transform_with_neurofibromatosis_1_type	rdfs:member	local:transform	.
local:particularly_those_with_inoperable_plexiform	rdfs:member	local:particularly_those	.
local:s0.2	rdf:predicate	local:summarize	.
local:s27	rdf:object	local:pool_rate_of_638_percent	.
local:pool_proportion	rdfs:subClassOf	local:proportion	.
local:s12.1	rdf:predicate	local:use	.
local:s12	rdf:subject	local:pool_objective_response_rat	.
local:s5	rdf:predicate	local:base	.
local:management_of_child_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:symptomatic_plexiform_neurofibroma	.
local:neurofibromatosis_type	rdfs:subClassOf	local:type	.
local:use_the_dersimonianlaird_method_base_on_randomeffects_model	rdfs:member	local:randomeffects_model	.
local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:neurofibromatosis_type	.
local:dersimonianlaird_method	rdfs:subClassOf	local:method	.
local:s1.2	rdf:predicate	local:neurofibromas	.
local:s15	rdf:subject	local:quality_of_the_evidence	.
local:s0.2	rdf:object	local:safety	.
local:s6.2	rdf:subject	local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	.
local:pubmed_to_28_january	rdfs:member	local:pubmed	.
local:633_percent	rdfs:subClassOf	local:percent	.
local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:child	.
local:five_study_analysis	rdfs:subClassOf	local:study_analysis	.
local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:child	.
local:s20	rdf:predicate	local:involve	.
local:s4.1	rdf:predicate	local:transform	.
local:efficacy_and_safety_of_selumetinib_in_child	rdfs:member	local:safety	.
local:objective_response	rdfs:member	local:objective	.
local:symptomatic_inoperable_plexiform_neurofibroma	rdfs:subClassOf	local:neurofibroma	.
local:efficacy_and_safety_of_selumetinib_in_patient	rdfs:member	local:efficacy	.
local:symptomatic_plexiform_neurofibroma_efficacy	rdfs:member	local:symptomatic_plexiform_neurofibroma	.
local:s0.1	rdf:subject	local:recent_approval_of_selumetinib	.
local:dersimonianlaird_method_base_on_randomeffects_model	rdfs:member	local:randomeffects_model	.
local:inoperable_plexiform_neurofibroma	rdfs:member	local:inoperable_plexiform	.
local:use_the_grade_of_assessment	rdfs:member	local:grade	.
local:s2.2	rdf:object	local:systematic_review	.
local:latest_study	rdfs:subClassOf	local:study	.
local:plexiform_neurofibroma_efficacy	rdfs:subClassOf	local:neurofibroma_efficacy	.
local:s15	rdf:predicate	local:assess	.
local:pool_rate	rdfs:subClassOf	local:rate	.
local:dersimonianlaird_method_base_on_randomeffects_model	rdfs:member	local:dersimonianlaird_method_base	.
local:longterm_outcome	rdfs:subClassOf	local:outcome	.
local:s8	rdf:subject	local:original_article	.
local:review_those	rdfs:subClassOf	local:those	.
local:plexiform_neurofibroma_efficacy	rdfs:subClassOf	local:efficacy	.
local:effective_treatment	rdfs:member	local:effective	.
local:selumetinib_be_an_safe_treatment_for_pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	rdfs:member	local:safe_treatment	.
local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:management	.
local:disease_control_rat	rdfs:member	local:disease_control	.
local:s8	rdf:object	local:efficacy_and_safety_of_selumetinib_in_patient	.
local:neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform	rdfs:member	local:inoperable_plexiform	.
local:s2.2	rdf:subject	local:neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform	.
local:confirm_the_longterm_outcome_of_patient	rdfs:member	local:longterm_outcome	.
local:s6.1	rdf:subject	local:recent_approval_of_selumetinib	.
local:pool_rate	rdfs:member	local:pool	.
local:s1	rdf:subject	local:recent_approval_of_selumetinib	.
local:s15.1	rdf:subject	local:grade_of_development	.
local:recent_approval	rdfs:subClassOf	local:approval	.
local:management_of_child_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:child_neurofibromatosis	.
local:s16	local:AM-ADV	local:use_the_grade_of_recommendation	.
local:s14.1	rdf:predicate	local:use	.
local:plexiform_neurofibroma	rdfs:member	local:plexiform	.
local:longterm_outcome_of_patient	rdfs:member	local:longterm_outcome	.
local:selumetinib_be_an_safe_treatment_for_pediatric_patient_with_symptomatic_inoperable_plexiform_neurofibroma	rdfs:member	local:symptomatic_inoperable_plexiform_neurofibroma	.
local:disease_control_rat	rdfs:subClassOf	local:rat	.
local:grade_of_evaluation_system	rdfs:member	local:grade	.
local:management_of_child_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:child_neurofibromatosis	.
local:s14	rdf:predicate	local:assess	.
local:s1.2	rdf:subject	local:neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform	.
local:up_to_28_january	rdfs:member	local:up	.
local:s6	rdf:subject	local:recent_approval_of_selumetinib	.
local:inoperable_plexiform	rdfs:member	local:inoperable	.
local:adverse_event	rdfs:subClassOf	local:event	.
local:management_of_child	rdfs:member	local:child	.
local:s6.1	rdf:object	local:management_of_child_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	.
local:pool_rate_of_638_percent	rdfs:member	local:percent	.
local:s32.1	rdf:object	local:longterm_outcome_of_patient	.
local:s9	rdf:subject	local:original_article	.
local:s0.2	rdf:subject	local:recent_approval_of_selumetinib_be_expect_to_transform_the_management_of_child_with_neurofibromatosis_type_1_particularly_those_with_symptomatic_plexiform_neurofibroma_no_systematic_review	.
local:original_article	rdfs:member	local:original	.
local:efficacy_of_selumetinib_in_patient	rdfs:member	local:efficacy_of_selumetinib	.
local:objective_response	rdfs:subClassOf	local:response	.
local:s1.2	rdf:object	local:systematic_review	.
local:management_of_child_neurofibromatosis_type_1_particularly_those_with_inoperable_plexiform_neurofibroma_no_systematic_review	rdfs:member	local:inoperable_plexiform_neurofibroma	.
local:creatine_kinase_level	rdfs:subClassOf	local:kinase_level	.
local:dersimonianlaird_method	rdfs:member	local:dersimonianlaird	.
local:symptomatic_plexiform	rdfs:subClassOf	local:plexiform	.
local:s7.1	local:AM-MNR	local:neurofibromatosis_type_1	.
local:s4.2	rdf:predicate	local:summarize	.
local:s16.1	rdf:predicate	local:use	.
local:grade_of_development	rdfs:member	local:grade	.
local:pool_rate_of_638_percent	rdfs:member	local:pool_rate	.
